February 15, 2021 Clinical Research Israeli study offers more evidence of Pfizer vaccine efficacy with 94% drop in symptomatic cases and 92% decrease in severe illness in people aged 55 and older.—- Restriction-easing plan in Ontario risks Yo-Yo effect once again.
February 14, 2021 Bariatric Medicine Not “game-changing” but another positive step forward for evidenced-based treatment to help people with #Overweight or #Obesity.
February 12, 2021 Epidemiology Who/what priority group is next in line with limited vaccine supply once those most at risk are vaccinated? Gut-wrenching decisions & no easy solutions considering Minorities, socioecon status, work environment, med hx, and other interconnected factors.
February 11, 2021 Epidemiology Variant spreading in North Bay, Ontario. Shutdown to continue for fear of rapid spread.
February 10, 2021 Epidemiology Ottawa Public Health reports first case of variant from South Africa. Will this intensify restrictions or will measures be relaxed next week by Ontario Government?
February 9, 2021 Allergy/Immunology Unpublished, uncontrolled small study claims that experimental exosome treatment shortens recovery time to five days for patients with severe Covid-19. Further human trials required to prove it truly works.
February 8, 2021 Epidemiology Some governments and businesses are preparing for the reality of endemic Covid-19 according to report in @WSJ
February 7, 2021 General information Many thanks to Jonathan Jarry @CrackedScience for an informative discussion about science miscommunication. #ScienceUpFirst #GoScience
February 5, 2021 General information Do people need a mask upgrade? @WSJ reviews the studies and some of the recommendations.
February 4, 2021 Allergy/Immunology Lancet posts Oxford Vaccine Group preprint study on how the timing of the booster dose of its Oxford-AZ vaccine affects the immune response and efficacy for people 18-55 years of age.